India's first dengue vaccine, Qdenga, is anticipated to launch in early 2027, potentially revolutionizing dengue prevention and addressing outbreaks across the country.
Qdenga is a live, attenuated tetravalent dengue vaccine
Aug 10, 2026
04:54 pm
What's the storyIndia's first dengue vaccine, Qdenga, is expected to be available by early 2027.
The vaccine is manufactured by Takeda Pharmaceutical and is a live, attenuated tetravalent dengue vaccine. It uses recombinant DNA technology and contains weakened versions of the four dengue virus serotypes to protect against the disease.
India plans to introduce electric air taxis by 2028, with technology testing accelerating next year, according to Union Civil…
India aims for electric air taxis to fly by 2028, with testing accelerating next year. Electric vertical take-off and landing…
India's electric vehicle battery demand will surge tenfold by 2032. This growth presents significant opportunities in component…
BYD India introduces the Seal U DM-i, its first plug-in hybrid model in the country, combining advanced powertrain technology…
India is poised to significantly boost its drone capabilities with a potential order exceeding $2 billion from domestic…
The Bengaluru startup makes fire-resistant, high-density batteries for drones and aerospace. It raised Rs 12 crore in a seed…
